Antiretroviral drugs have greatly extended the life span of HIV-infected persons, but research suggests they are in high risk of developing diabetes (Nduka et al., 2017). A new tool to preserve vital cells for diabetes treatment can help people with both conditions. Scientists can now save most pre-transplant ‘islet cells’ derived from donors that are vital to restore insulin production in Type 1 diabetes patients. This is important news for HIV positive people, who are on antiretroviral therapy (ART).
Keywords: HIV, antiretroviral therapy, diabetes